Comorbid depression in medical diseases

被引:342
作者
Gold, Stefan M. [1 ,2 ,3 ]
Kohler-Forsberg, Ole [4 ,5 ,6 ]
Moss-Morris, Rona [7 ]
Mehnert, Anja [8 ]
Miranda, J. Jaime [9 ]
Bullinger, Monika [10 ]
Steptoe, Andrew [11 ]
Whooley, Mary A. [12 ]
Otte, Christian [1 ]
机构
[1] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Berlin Inst Hlth BIH,Klin Psychiat & Psychotherap, Campus Benjamin Franklin, Berlin, Germany
[2] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Berlin Inst Hlth BIH,Med Klin mS Psychosomat, Campus Benjamin Franklin, Berlin, Germany
[3] Univ Klinikum Hamburg Eppendorf, Inst Neuroimmunol & Multiple Sklerose INIMS, Hamburg, Germany
[4] Aarhus Univ Hosp Psychiat, Dept Affect Disorders, Aarhus, Denmark
[5] Aarhus Univ, Dept Clin Med, Aarhus, Denmark
[6] Aarhus Univ Hosp Psychiat, Psychosis Res Unit, Aarhus, Denmark
[7] Kings Coll London KCL, Inst Psychol Psychiat & Neurosci, Psychol Dept, Guys Hosp Campus, London, England
[8] Univ Klinikum Leipzig, Abt Med Psychol & Med Soziol, Leipzig, Germany
[9] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru
[10] Unversitatsklinikum Hamburg Eppendorf, Inst & Poliklin Med Psychol, Hamburg, Germany
[11] UCL, Dept Behav Sci & Hlth, London, England
[12] Univ Calif San Francisco UCSF, San Francisco VA Hlth Care Syst, San Francisco, CA USA
基金
英国惠康基金; 英国医学研究理事会; 瑞士国家科学基金会;
关键词
QUALITY-OF-LIFE; SEROTONIN REUPTAKE INHIBITORS; COGNITIVE-BEHAVIORAL THERAPY; HEALTH QUESTIONNAIRE PHQ-9; CORONARY-HEART-DISEASE; WEB-BASED INTERVENTION; CO-MORBID DEPRESSION; MULTIPLE-SCLEROSIS; MAJOR DEPRESSION; CHRONIC ILLNESS;
D O I
10.1038/s41572-020-0200-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Depression is one of the most common comorbidities of many chronic medical diseases including cancer and cardiovascular, metabolic, inflammatory and neurological disorders. Indeed, the prevalence of depression in these patient groups is often substantially higher than in the general population, and depression accounts for a substantial part of the psychosocial burden of these disorders. Many factors can contribute to the occurrence of comorbid depression, such as shared genetic factors, converging biological pathways, social factors, health behaviours and psychological factors. Diagnosis of depression in patients with a medical disorder can be particularly challenging owing to symptomatic overlap. Although pharmacological and psychological treatments can be effective, adjustments may need to be made for patients with a comorbid medical disorder. In addition, symptoms or treatments of medical disorders may interfere with the treatment of depression. Conversely, symptoms of depression may decrease adherence to treatment of both disorders. Thus, comprehensive treatment plans are necessary to optimize care. Major depressive disorder is common in patients with medical diseases and accounts for a substantial part of the psychosocial burden of these diseases. This Primer discusses the epidemiology, mechanisms, diagnosis and treatment of comorbid depression in patients with medical diseases.
引用
收藏
页数:22
相关论文
共 299 条
[1]   Health Care Contacts in the Year Before Suicide Death [J].
Ahmedani, Brian K. ;
Simon, Gregory E. ;
Stewart, Christine ;
Beck, Arne ;
Waitzfelder, Beth E. ;
Rossom, Rebecca ;
Lynch, Frances ;
Owen-Smith, Ashli ;
Hunkeler, Enid M. ;
Whiteside, Ursula ;
Operskalski, Belinda H. ;
Coffey, M. Justin ;
Solberg, Leif I. .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2014, 29 (06) :870-877
[2]   Depression treatment and health-related quality of life among adults with diabetes and depression [J].
Alenzi, Ebtihag O. ;
Sambamoorthi, Usha .
QUALITY OF LIFE RESEARCH, 2016, 25 (06) :1517-1525
[3]  
Allida S, 2020, COCHRANE DATABASE SY, V1, pCD0033437
[4]  
American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI 10.1176/appi.books.9780890425596
[5]   Depression comorbidity in migraine [J].
Amoozegar, Farnaz .
INTERNATIONAL REVIEW OF PSYCHIATRY, 2017, 29 (05) :504-515
[6]  
[Anonymous], 2015, MEDICINE
[7]  
[Anonymous], Mental health and substance use: mental health gap action programme (mhGAP)
[8]  
[Anonymous], 2012, J AFFECT DISORDERS, DOI DOI 10.1007/S10840-012-9674-5
[9]  
[Anonymous], 2018, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD008525.PUB3
[10]  
[Anonymous], 2009, PAT REP OUTC MEAS US